Functional hypersplenism in mice induced by adoptive transfer of syngeneic spleen cells.
Investigation of peripheral blood cell count alterations in cases with hypersplenism, and an understanding of the relationship between splenic function and hematopoietic cell production require suitable experimental animal models. Previously described methods are either traumatic or require surgical intervention. We suggest a relatively simple method for achievement of a state mimicking hypersplenism in mice by intraperitoneal inoculation of syngeneic spleen cells. Mice were inoculated intraperitoneally with 3 x 10(7) splenocytes suspended in 0.3 ml phosphate buffered saline (PBS). After 2 months, the inoculated animals showed a progressive decrease in the peripheral white blood cell (WBC) counts and hyperplastic bone marrow that persisted until the experimental end point (7 months). Five days after inoculation of splenocytes stained with carboxy-fluorescein diacetate succinimidyl ester (CFSE), the majority of the stained cells was present in the peritoneal cavity (33%) and in the liver (13%), whereas the percentage of stained cells in the peripheral blood and the spleen cell suspension was negligible. The mitogen response of the peripheral blood mononuclear cells (PBMC) from treated mice to concanavalin A (Con A) remained unaltered. Splenocyte-inoculated mice that were further splenectomized did not show leukocytosis after splenectomy, as was observed in animals in which the spleen was removed without any pretreatment. The lack of any signs of discomfort in animals from the study group, in comparison with the visibly ill appearance and even death of mice in which hypersplenism was achieved by repeated injections of methylcellulose (MC), which served as controls, favors the convenience of the method.
Salman
Hertzel
H
Department of Medicine C, Rabin Medical Center-Golda Campus, Petah-Tiqva, Israel.
Bessler
Hanna
H
Bergman
Michael
M
Fibach
Eitan
E
Djaldetti
Meir
M
D019264:Adoptive Transfer / Q000009:adverse effects* / Q000379:methods; D000818:Animals; D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology; D003208:Concanavalin A / Q000008:administration & dosage / Q000494:pharmacology; D005456:Fluorescent Dyes; D006971:Hypersplenism / Q000209:etiology* / Q000473:pathology; D007274:Injections, Intraperitoneal; D007962:Leukocytes / Q000378:metabolism / Q000473:pathology; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D007964:Leukocytosis / Q000378:metabolism; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008747:Methylcellulose / Q000008:administration & dosage / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D010529:Peritoneal Cavity / Q000473:pathology*; D013154:Spleen / Q000473:pathology*; D013156:Splenectomy / Q000379:methods; D014185:Transplantation, Isogeneic
D005456:Fluorescent Dyes; D003208:Concanavalin A; D008747:Methylcellulose